Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of two salvage regimens for Helicobacter pylori eradication in non-responder dyspeptic patients
IRCT201103011155N11Phase 2Completed
- Sponsor
- Research Vice Chancellorship of Guilan University of Medical Sciences
- Start
- Feb 2011
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of bismuth subcitrate, omeprazole, amoxicillin, clarithromycin, tinidazole and 3 more in Helicobacter pylori infection and dyspepsia (2 arms), sponsored by Research Vice Chancellorship of Guilan University of Medical Sciences. Primary endpoint: Helicobacter pylori eradication rate. Started Feb 2011; status: completed.
02
Drugs
bismuth subcitrateomeprazoleamoxicillinclarithromycintinidazole
03
Conditions
Helicobacter pylori infectiondyspepsia
Beyond the preview
Go deeper on IRCT201103011155N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201103011155N11.